Total synthesis of the cylindrospermopsin alkaloids
Total synthesis of the cylindrospermopsin alkaloids
批准号:
EP/J01821X/1
负责人:
Patrick Murphy
金额:
$23.53万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2012
资助国家:
英国
项目状态:
已结题
起止时间:
2012 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The proposed research is concerned with the synthesis of a family of naturally occurring marine natural products namely cylindrospermopsin , 7-epi-cylindrospermopsin and 7-deoxy-cylindrospermopsin, which are found in several species of blue-green algae. Cylindrospermopsin was originally isolated from a bloom of Cylindrospermopsis raciborskii after an outbreak of a mystery disease on Palm Island in Queensland, Australia. Its unique structure, consisting of uracil ring and a zwitterionic guanidinium/sulfate combination imparts very high water solubility and it is this property which poses a potential threat to water supplies. The biological activity of cylindrospermopsin centers on its toxicity to liver and kidney tissue, its ability to inhibit protein synthesis as well as being able to covalently modify both DNA and RNA. Synthetic efforts toward the natural product have been reported by other groups using linear and convergent strategies, however overall yields for these are generally low (0.2-2% yield) and require a considerable number of operations (19-36 steps)The goal of this project is to develop our already proven approach to a model of the metabolites into a total synthesis of the three molecules via a synthesis mimicking that found in nature (biomimetic). This methodology is convergent in nature and will be shorter than any other reported previously, thus being flexible enough to enable the rapid preparation of the three metabolites. In addition to this, it is hoped that a flexible and rapid method for the preparation of synthetic analogues will emerge from this methodology, enabling the study of the biological mode of action of these compounds. This in turn will lead to an understanding of the structural requirements for biological action and the potential for preparing less toxic analogues, which retain the required activity.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3987/com-20-14236
发表时间:
2020-04-01
期刊:
HETEROCYCLES
影响因子:
0.6
作者:
[Ashworth, Zackary J. R., Bartholomew, Barbara, Murphy, Patrick J.]
通讯作者:
Murphy, Patrick J.
Preparation of an ABC tricyclic model of the cylindrospermopsin alkaloids via a biomimetically inspired pathway
通过仿生途径制备圆柱精蛋白生物碱的 ABC 三环模型
DOI:
10.1039/c4ra03031a
发表时间:
2014
期刊:
RSC Adv.
影响因子:
--
作者:
[Evans D]
通讯作者:
Evans D
DOI:
10.1039/c9ra07508a
发表时间:
2020-06-10
期刊:
RSC ADVANCES
影响因子:
3.9
作者:
[Al-Taie, Zahraa S., Anetts, Simon R., Christensen, Jeppe, Coles, Simon J., Horton, Peter N., Evans, Daniel M., Jones, Leigh F., de Kleijne, Frank F. J., Ledbetter, Shaun M., Mehdar, Yassin T. H., Murphy, Patrick J., Wilson, Jack A.]
通讯作者:
Wilson, Jack A.
Iodocyclisations reactions of Boc- and Cbz-protected N-allylguanidines
Boc 和 Cbz 保护的 N-烯丙基胍的碘环化反应
DOI:
10.1016/j.tet.2014.03.087
发表时间:
2014
期刊:
Tetrahedron
影响因子:
2.1
作者:
[Al Shuhaib Z]
通讯作者:
Al Shuhaib Z
DOI:
10.1016/j.tet.2015.11.058
发表时间:
2016-01-28
期刊:
TETRAHEDRON
影响因子:
2.1
作者:
[Allingham, Matthew T., Bennett, Elliot L., O'Donoghue, AnnMarie C.]
通讯作者:
O'Donoghue, AnnMarie C.
共 7 条
MRI: Acquisition of an FPLC Liquid Chromatography System for Use in Biomolecule Purification, Protein Analysis, and Research Training at Seattle University
-
批准号:0923580
-
项目类别:Standard Grant
-
资助金额:$12.96万
-
财政年份:2009
-
负责人:Patrick Murphy
-
依托单位:
国内基金
海外基金
登录
查看更多内容
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
“肠—肝轴”PPARα/CYP8B1胆汁酸合成信号通路在减重手术改善糖脂代谢中的作用与机制
-
批准号:82370902
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:田景琰
-
依托单位:
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
-
批准号:32372856
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李隐侠
-
依托单位:
脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
-
批准号:82372203
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李然然
-
依托单位:
环状RNA circ-PRKAA1调控肝癌细胞脂代谢重编程的研究
-
批准号:32000527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:李启东
-
依托单位:
ALDH6A1缺损重塑糖脂代谢促进肝细胞癌发生的机制研究
-
批准号:91957109
-
项目类别:重大研究计划
-
资助金额:79.0万元
-
批准年份:2019
-
负责人:黄赞
-
依托单位:
新型滤波器综合技术-直接综合技术(Direct synthesis Technique)的研究及应用
-
批准号:61671111
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:肖飞
-
依托单位:
双硅化合物反应及天然产物合成应用研究
-
批准号:21172150
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:宋振雷
-
依托单位:
新型M4受体选择性拮抗剂的研究
-
批准号:30973615
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2009
-
负责人:何新华
-
依托单位:
基于penicillide结构的类天然产物合成及其胆固醇酯转运蛋白抑制的研究
-
批准号:20872019
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:雷新胜
-
依托单位: